The list of articles is refreshed every 15 minutes so you can be sure of the latest information.
Click the following link to view the sources used on this page.
Minutes since last refreshed: 0 (20:15 on 23 June 2018)
Identifier: REC-AG-2017Pillar: REC Programme 2014-2020Opening Date: Deadline: Tue, 7 Nov 2017 17:00:00 (Brussels local time)Modification Date: Fri, 22 Jun 2018Latest information: Call update flash info document has been added under Topic conditions and documents - Additional documents.
The event will provide insight on the FLYSEC project results and their alignment with the implementation of the joint IATA/ACI Smart Security programme, while contributing to the overall picture of the EU research portfolio and agenda by inviting key cluster projects in the relevant area of airport, border and risk based security paradigm shift. The events’ panel discussion will focus on extending the European and Global view on facilitating the adoption of resulting assets, security principles, recommendations and values by policy makers, regulators and high level decision makers, in the context of enhancing security, improving passenger experience and optimising operational resources, while simultaneously taking into account increasing requirements in the context of GDPR compliance, ethics and respect for human rights and dignity. If you have any questions regarding the FlySec event, please feel free to contact us by telephone at +302106503182 or via email at edoukoudaki@iit.
Management and treatment of neurological diseases is one of the biggest challenges facing medicine today. EU-funded researchers are developing computational tools to improve understanding of how such diseases progress as a means to help treat
The last special workshop of the EU funded Best Paths project will show the results of the Demonstration 5, which is developing a new superconducting direct current cable enabling power transmission of several gigawatts. The workshop, organised by Nexans, IASS Potsdam and ASG Superconductors, will also discuss the future European grid and the opportunities for integrating superconducting transmission links. The day will include a visit of Columbus Superconductors, which is a world leader in the manufacturing of superconducting wires.
An EU-funded project aims to identify and maximise the potential of novel vaccines to end the global tuberculosis epidemic. These could save lives, stem the spread of infection and shorten treatment for the often deadly, airborne disease.
At an award ceremony in Brussels, Commissioner for Research, Science and Innovation Carlos Moedas and MEP Eva Kaili announced the four winners of the 2018 EU Prize for Women Innovators, funded under Horizon 2020, the EU research and innovation programme.
Identifier: H2020-SC1-BHC-2018-2020Pillar: Societal ChallengesOpening Date: Deadline: Wed, 18 Apr 2018 17:00:00 (Brussels local time)Modification Date: Wed, 20 Jun 2018Latest information: Please find the document referred to in BHC-22-2019 (footnote 1) here: Framework for action on Mental Health and Wellbeing
Why does the body attack itself? EU-funded researchers have discovered new details about how faults in a specific gene trigger such activity, increasing our understanding of the roots of autoimmune diseases like arthritis and lupus and raising hopes of finding new treatment approaches.
Identifier: H2020-RUR-2018-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Wed, 23 Jan 2019 17:00:00 (Brussels local time)Modification Date: Wed, 20 Jun 2018Latest information: PRE-INFORMATION NOTICE This page aims to inform H2020 applicants that the Commission is planning to publish a new H2020 Rural Renaissance topic (RUR-20-2018). This pre-information notice is published for information purposes only. If you are interested in applying, you are advised to wait for the publication of the call text and consult regularly the "Calls for Proposals" page. The pre-information page also contains an indicative call publication date, call deadline and budget, and the draft topic text.
For patients with rare genetic mutations of the debilitating disease cystic fibrosis, there are few options for effective treatment. EU-funded researchers are working to meet their needs, using new developments in personalised medicine to advance the testing of novel an